Night shifts may be linked to increased ovarian cancer risk

Working night shifts might increase the risk of developing ovarian cancer, indicates research published in Occupational and Environmental Medicine.

The risk may be lower for night types ("") than for morning types ("larks"), the findings suggest (see accompanying commentary).

The authors base their findings on 1101 women with the most common type (epithelial) of advanced ; 389 with borderline disease; and a comparison group of 1832 women without ovarian cancer.

The women, who were all aged between 35 and 74, were asked about the hours they worked, including whether they had ever worked night shifts.

The International Agency for Research on Cancer (IARC) has classified that disrupts the body's normal time clock (circadian ) as a cancer causing agent. And other research has suggested that shift work may be associated with an increased risk of breast cancer.

Among the women with , around 1 in 4 (26.6%; 293) had ever worked nights, compared with 1 in 3 (32.4%; 126) of those with borderline disease and around 1 in 5 (22.5%; 412) of the comparison group.

Use of the Pill was lower among women with ovarian cancer, who also tended to have had fewer children than those without the disease. Being on the Pill and are known to lower the risk of ovarian cancer.

The stint of night shifts averaged between 2.7 and 3.5 years across all three groups of women, with jobs in healthcare, and service, and office and admin support the most common types of employment.

Working night shifts was associated with a 24% increased risk of advanced cancer and a 49% increased risk of early stage disease compared with those who worked normal office hours.

A greater proportion (27%) of women who described themselves as "owls" had worked night shifts than women (20%) who were "larks".

The risks of either advanced ovarian cancer were slightly higher (29%) among "larks" than among "owls" (14%), although difference this was not statistically significant. Findings were similar for borderline tumours - 57% and 43% for "larks" and "owls," respectively.

Only women aged 50 and above were significantly more likely to have ovarian cancer if they had worked nights.

The authors say their findings are consistent with, and of a similar magnitude, as those found for , but point out that they did not find any cumulative risk for ovarian cancer the longer a woman had worked a night shift pattern.

One possible explanation could be linked to melatonin, a powerful hormone that is normally produced at night, but suppressed by ambient light, and which regulates reproductive hormones, particularly oestrogen.

Melatonin also scavenges harmful free radicals and boosts production of other antioxidants in the body.

More information: Nightshift work and risk of ovarian cancer, doi: 10.1136/oemed-2012-101146

Editorial: Shift work and cancer research: can chronotype predict susceptibility in night-shift and rotating-shift workers? Doi: 10.1136/oemed-2012-100984

Related Stories

Does night work put women's health at risk?

Jun 19, 2012

Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France.

Study links obesity to elevated risk of ovarian cancer

Jan 05, 2009

A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. Published in the ...

Recommended for you

Endogenous hormones improve breast cancer risk models

7 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

8 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments